MPM BioImpact
Overview
MPM BioImpact is a biotechnology investment firm that creates and invests in private and public companies developing transformative therapies and life-saving drugs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aktis Oncology | Sep 2024 | Series B | - |
| Tizona Therapeutics | Mar 2016 | Series B | Co-investor |
| Umoja Biopharma | Jan 2025 | Series C | - |
| Clinical Ink | Mar 2015 | VC Round | Lead |
| ReCode Therapeutics | Oct 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is MPM BioImpact based?
MPM BioImpact is headquartered in Boston, Massachusetts, United States.
When was MPM BioImpact founded?
MPM BioImpact was founded in 1997.
How many portfolio companies does MPM BioImpact have?
MPM BioImpact has 29 portfolio companies in Caplight's dataset.
What are some companies in MPM BioImpact's portfolio?
Portfolio companies visible on Caplight include Aktis Oncology, Tizona Therapeutics, Umoja Biopharma, Clinical Ink, ReCode Therapeutics.
What was MPM BioImpact's most recent investment shown here?
MPM BioImpact's most recent investment in this portfolio sample was in Umoja Biopharma in 2025.
What sectors does MPM BioImpact focus on?
MPM BioImpact focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does MPM BioImpact focus on?
MPM BioImpact typically invests at the MultiStage stage.
What is MPM BioImpact's AUM?
MPM BioImpact's assets under management are estimated between $1.0B and $10.0B.